title: Industry-academia collaborations for biomarkers.
abstract: Several types of collaboration are being pursued to identify, validate and apply new biomarkers. Here, we highlight examples of such initiatives and discuss the challenges, approaches to address these challenges and key factors for success.
authors.affiliation: Bayer Global Drug Discovery, Müllerstrasse 178, 13353 Berlin, Germany.|Charité University Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany.
authors.forename: Khusru
authors.initials: K
authors.lastname: Asadullah
authors.affiliation: Bayer Global Drug Discovery, Müllerstrasse 178, 13353 Berlin, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Busch
authors.affiliation: Bayer Global Drug Discovery, Müllerstrasse 178, 13353 Berlin, Germany.
authors.forename: Matthias
authors.initials: M
authors.lastname: Gottwald
authors.affiliation: Charité University Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany.
authors.forename: Petra
authors.initials: P
authors.lastname: Reinke
authors.affiliation: Charité University Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany.|Potsdam General Hospital, Charlottenstrasse 72, 14467 Potsdam, Germany.
authors.forename: Lilla
authors.initials: L
authors.lastname: Landeck
mesh_terms: D015415:Biomarkers; D035843:Biomedical Research / Q000379:methods / Q000458:organization & administration; D003299:Cooperative Behavior; D019937:Diagnostic Techniques and Procedures; D055808:Drug Discovery / Q000458:organization & administration*; D004335:Drug and Narcotic Control / Q000458:organization & administration; D006801:Humans; D007221:Industry / Q000458:organization & administration*; D033183:Interdisciplinary Communication; D017146:Models, Organizational
chemical_list: D015415:Biomarkers